Gujarat Terce Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 120.3 million compared to INR 125.76 million a year ago. Revenue was INR 121.14 million compared to INR 126.78 million a year ago. Net income was INR 3.35 million compared to net loss of INR 5.89 million a year ago. Basic earnings per share from continuing operations was INR 0.45 compared to basic loss per share from continuing operations of INR 0.79 a year ago. Diluted earnings per share from continuing operations was INR 0.45 compared to diluted loss per share from continuing operations of INR 0.79 a year ago.
For the six months, sales was INR 227.47 million compared to INR 219.89 million a year ago. Revenue was INR 229.07 million compared to INR 221.58 million a year ago. Net loss was INR 9.73 million compared to INR 24.72 million a year ago. Basic loss per share from continuing operations was INR 1.31 compared to INR 3.33 a year ago. Diluted loss per share from continuing operations was INR 1.31 compared to INR 3.33 a year ago.